SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,764.23 -813.35
( -1.08%)

Global Indices

Nasdaq

52,820.00 -615.25
(-1.15%)

Dow Jones

7,695.68 -43.92
(-0.57%)

Hang Seng

65,089.68 -179.65
(-0.28%)

Nikkei 225

10,664.98 -146.68
(-1.36%)

Forex

USD-INR

94.51 0.08
(0.08%)

EUR-INR

109.83 0.16
(0.15%)

GBP-INR

127.88 0.26
(0.20%)

JPY-INR

0.61 0.01
(0.93%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

423.3553764

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

33.7

110515.04

EPS(TTM)

Face Value()

Div & Yield %

40.59

0.95

Back

Cipla consolidated net profit declines 39.19% in the June 2026 quarter

Jul 23,2026

Net profit of Cipla declined 39.19% to Rs 789.05 crore in the quarter ended June 2026 as against Rs 1297.62 crore during the previous quarter ended June 2025. Sales rose 3.51% to Rs 7077.02 crore in the quarter ended June 2026 as against Rs 6837.04 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	7077.02	6837.04	4
OPM %	16.85	26.01	-
PBDT	1386.17	2022.65	-31
PBT	1081.93	1769.93	-39
NP	789.05	1297.62	-39

74,764.23 -813.35 ( -1.08%)

52,820.00 -615.25 (-1.15%)

7,695.68 -43.92 (-0.57%)

65,089.68 -179.65 (-0.28%)

10,664.98 -146.68 (-1.36%)

94.51 0.08 (0.08%)

109.83 0.16 (0.15%)

127.88 0.26 (0.20%)

0.61 0.01 (0.93%)